Why do patients with liver metastases respond so poorly to cancer immunotherapy? Here we find a new immunological mechanism in MMR-d cancers centering on IL-18 and γδ T cells.👇 www.cell.com/cell-reports... @cp-cellrepmed.bsky.social

Liver metastases dampen IL18-driven γδ T cell activity and immunotherapy responsiveness in colorectal cancer @cp-cellrepmed.bsky.social www.cell.com/cell-reports...

Taking over the hospital for prideweek with gendercupcakes @nkinl.bsky.social @florencevb.bsky.social #diversity

💥 Really excited to say that our paper with Karin de Visser and @dewitlab.bsky.social is now online! A beautiful story to culminate years of great collaboration and teamwork at the @nkinl.bsky.social. A 🧵 www.sciencedirect.com/science/arti...

Nature research paper: Spatial mapping of transcriptomic plasticity in metastatic pancreatic cancer https://go.nature.com/4jonL1b

While diversity initiatives are under attack, at the netherlands cancer institute (@nkinl.bsky.social) we firmly believe in creating an inclusive & diverse environment! Together with Humanity in Action we hosted a workshop about recognizing and prevent discrimination in healthcare & academia

Implantation of engineered adipocytes suppresses tumor progression in cancer models - @nadavahituv.bsky.social go.nature.com/4gqhxvw

The next frontier of T cell therapeutics when the T also stands for tissue-targeting, such as brain or local immune response, via synthetic gene circuits @science.org science.org/doi/10.1126/... science.org/doi/10.1126/... science.org/doi/10.1126/...